Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2020-01-31
2020-02-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factors and Computed Tomography Findings in COVID-19.
NCT04577105
Chest Ultrasound Versus Chest X-ray with Ct As Gold Standard At Trauma Patients
NCT06699277
Impact of the CT Scan in Patients With Suspected Covid-19
NCT05079191
Pulmonary CT in Pneumonia Complicating Stroke
NCT03106909
The Place of Imaging and Microbiology in the Diagnosis of Pneumonia in the Elderly
NCT02467192
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High CT score
CT score
CT score = normal lung tissue (%) ×1 + GGO (%) ×2 + consolidation (%) ×3
Low CTscore
CT score
CT score = normal lung tissue (%) ×1 + GGO (%) ×2 + consolidation (%) ×3
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CT score
CT score = normal lung tissue (%) ×1 + GGO (%) ×2 + consolidation (%) ×3
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ruilan Wang
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wuhan third hospital
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CT2019-nCoV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.